On August 2, 2021 Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology, reported that Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer, will participate in the Wedbush PacGrow Healthcare Conference, to be held virtually from August 10-11, 2021 (Press release, Apexigen, AUG 2, 2021, View Source [SID1234590988]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wedbush PacGrow Healthcare Conference
Panel discussion: For Your IOnly – Progress, Challenges in Immuno-Oncology
Wednesday, August 11, 2021, at 12:35 p.m. ET

The webcast of the Wedbush panel discussion will be accessible in the News & Events section of the Apexigen website at View Source